Clinical Trial Update: Treatment of Moderate to Severe Refractory Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/Phase 2 clinical trials are evaluating a treatment for moderate to severe refractory Crohn's disease. Recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Tr1X, Inc. | Conditions: Crohns Disease | Phase 1, Phase 2 | Status: RECRUITING